Harmony Biosciences Holdings Inc. (HRMY): Price and Financial Metrics Recent IPO
Harmony Biosciences Holdings Inc. (HRMY) Recent IPO
Today's Latest Price: $46.65 USD
Updated Nov 24 4:00pm
Add HRMY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
HRMY Stock Price Chart Interactive Chart >
HRMY Price/Volume Stats
| Current price | $46.65 | 52-week high | $52.74 |
| Prev. close | $42.60 | 52-week low | $28.97 |
| Day low | $41.95 | Volume | 186,600 |
| Day high | $46.78 | Avg. volume | 213,785 |
| 50-day MA | $38.58 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 2.65B |
Harmony Biosciences Holdings Inc. (HRMY) Company Bio
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders. Its product WAKIX is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded on July 25, 2017 and is headquartered in Plymouth Meeting, PA.
Loading social stream, please wait...